Cargando…
Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy
Non-small cell lung cancer (NSCLC) is a highly malignant tumor, with a significant mortality and morbidity. With the development of tumor immunotherapy, chimeric antigen receptor T cells (CART) gets increasingly attention and achieves prominent contributions in the treatment of hematologic malignanc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681039/ https://www.ncbi.nlm.nih.gov/pubmed/34896852 http://dx.doi.org/10.1016/j.tranon.2021.101309 |